Study to Improve Survival Among HIV-Exposed Infants in Botswana
Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find ways to improve infant health and survival among infants
whose mothers are HIV-infected but who do not themselves have HIV.
Phase:
Phase 2
Details
Lead Sponsor:
Harvard School of Public Health Harvard School of Public Health (HSPH)
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Harvard Medical School Harvard Medical School (HMS and HSDM) National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Sulfamethoxazole Trimethoprim Trimethoprim, Sulfamethoxazole Drug Combination